Management of Cold Agglutinin Disease in the Emergency Department: A Case-Based DiscussionPremiere Date: Friday, June 14, 2019
This activity offers CE credit for:%>
- Physicians (CME)
- Pharmacists (ACPE)
- ABIM (MOC)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, December 31, 2020
|Joseph E. Kiss, MD
Clinical Apheresis and Blood Services
Professor of Medicine
Division of Hematology - Oncology
University of Pittsburgh
|Lauren E. Siewny, MD
Assistant Professor of Surgery
Department of Surgery, Division of Emergency Medicine
Duke University Medical Center
Cold Agglutinin Disease (CAD) is an idiopathic disease that primarily effects patients over 50, and patients with this benign rare blood disorder frequently present to the emergency department with bleeding-related issues. Because of this, it is important for physicians and other health care professionals in the ED to be educated about optimal approaches for treating and monitoring patients with CAD.
In this CME Outfitters Snack, updated guidelines and new treatments are highlighted in a video case identifying CAD in the ED and providing appropriate management, including ensuring best practices for blood testing and blood transfusion in patients with CAD.
At the end of this CE activity, participants should be able to:
- Recognize and manage complications associated with benign rare blood disorders such as CAD in the emergency department setting.
- Evaluate clinical data for the efficacy and safety of current and emerging treatments for benign rare blood disorders.
- Implement personalized, evidence-based approaches to managing benign rare blood disorders in the emergency department setting.
The following learning objectives pertain only to those requesting CNE or CPE credit:
- Explain the complications associated with benign rare blood disorders such as CAD in the emergency department setting.
- Describe the clinical data for the efficacy and safety of current and emerging treatments for benign rare blood disorders.
- Identify personalized, evidence-based approaches for managing benign rare blood disorders in the emergency department setting.
Supported by educational grants from CSL Behring LLC and Shire, now part of Takeda.
Emergency Department physicians, physician assistants, nurse practitioners, nurses, and pharmacists.
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 0.5 contact hours (0.05 CEUs) Universal Activity Number:
ABIM MOC Credit:
MOC Points available for Internal Medicine and General Medicine Board Certified Physicians.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
MIPS Improvement Activity: This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
Note to Nurse Practitioners: Nurse Practitioners can apply for AMA PRA Category 1 Credit™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Kiss reports that he receives grants from Bioverativ, Inc (now part of Sanofi).
Dr. Siewny has no disclosures to report.
Jeffrey Helfand, DO, MS (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Kavitha Ramachandran, PhD (planning committee) has no disclosures to report.
Evan Luberger (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).